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Abstract
The square antiprism/twisted square antiprism ratio in LnDOTA-tetraamide chelates is a critical
parameter in governing water-exchange kinetics and ultimately the utility of a chelate as a
PARACEST MRI contrast agent. In LnDOTA-tetraamide chelates with tertiary amides, this ratio
and the rate of interconversion between these two structural isomers are found to be dramatically
dependent upon the solvent and possibly other local environmental factors.
The realization that Ln3+ chelates with slowly exchanging inner-sphere water molecules
could induce magnetic resonance imaging (MRI) contrast through a paramagnetic chemical
exchange saturation transfer (PARACEST) mechanism has given rise to a recent upsurge in
interest in LnDOTA-tetraamide chelates.1,2 The large paramagnetic hyperfine chemical
shifts induced by anisotropic 4f electrons effectively shift the resonance of the inner-sphere
water far from that of solvent water. However, because unchelated Ln3+ ions are toxic,
suitable chelating ligands must be employed that both eliminate the toxic effects3 of these
ions and appropriately slow water exchange.1,2,4,5 Ligands derived from cyclen have been
widely accepted in the development of MRI contrast agents,3 and the related DOTA-
tetraamide ligands (Chart 1) are now widely studied as PARACEST agents. Although
DOTA-tetraamide chelates are kinetically inert, retaining the Ln3+ ion throughout the in
vivo residence of the chelate,6,7 the use of DOTA-tetraamide ligands in vivo can be
problematic. It has been shown that only when the cationic nature of these chelates is offset
by anionic substituents, such as carboxylates, can the severe toxic effects intrinsic to cationic
chelates be avoided at the relatively high dosing levels required for MRI.6 A chelate
incorporating four glycinateamide substituents has been shown to be safe for in vivo use.6,7
The unique water-exchange characteristics of these chelates make them attractive as MRI
sensors of various biological species such as glucose, Zn2+, or protons (pH),8–11 but this
normally requires the addition of side-chain substituents that act as binding sites for such
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species. In such situations, it may be desirable to incorporate the offsetting negative charges
as tertiary amide substituents, leaving the sensing secondary amide substituents in place.
However, DOTA-tetraamides with tertiary amide pendant arms have not been widely
studied as PARACEST agents. Of particular relevance is the coordination chemistry of these
chelates. LnDOTA-tetraamide chelates can adopt both a monocapped square antiprismatic
(SAP) and a monocapped twisted square antiprismatic (TSAP) coordination geometry,4,5
and it has been shown that water exchange in complexes that form a TSAP isomer is 1–2
orders of magnitude faster than that in complexes that form a SAP isomer.4,5,12 Given the
requirement for slow exchange kinetics in putative PARACEST agents, it is clearly
preferable for the SAP coordination geometry to predominate. Indeed, to our knowledge, the
rate of exchange observed in the TSAP isomers of these complexes is so fast that CEST
arising from this species has not been observed.
The only substantive literature contributions concerning tertiary LnDOTA-tetraamides are
reports about the simple dimethyl ligand, DOTTA (Chart 1).4,5 This ligand is notable in that,
unlike other simple tetraamides such as DOTAM and DTMA, it was reported to exhibit a
strong (2:1) preference for the TSAP coordination geometry in D2O. However, in secondary
amide systems, larger substituents have generally been found to have an overwhelming
preference for the SAP isomer.13,14 This raised the question of what happens in tertiary
DOTA-tetraamide systems in which larger substituents are employed. In response, the
structural isomerism of some symmetrically substituted tertiary DOTA-tetraamide chelates
are examined herein.
Ligands 1, 2, and DOTTA were prepared by condensation of the appropriate secondary
amine with a haloacetyl halide (CH2Cl2/K2CO3); the resulting haloacetamides were then
used to alkylate cyclen under standard conditions.5,13 After purification by either column
chromatography or reversed-phase high-performance liquid chromatography (RP-HPLC), as
appropriate, Ln3+ complexes of each ligand were prepared from the corresponding Ln(OTf)3
salt. Because the nature of the counterion in this type of complex is known to affect the
structure and water-exchange properties of the complex,15 triflate counterions were used
throughout this work to eliminate changes in behavior arising from differences in the
counterion. Our initial hypothesis was that the SAP/TSAP ratio across the Ln series could be
examined by 1H NMR by taking advantage of the known difference in the chemical shifts of
the axial ring protons (axS) to both identify and quantify each coordination isomer.16,17
However, the SAP and TSAP isomers are in dynamic equilibrium, interconverting through
either pendant arm rotation or flipping of the macrocyclic ring conformation.18,19 If this
interconversion is fast on the NMR time scale, then identifying and quantifying the two
isomeric forms of a chelate can only be achieved by lowering the temperature, something
that may necessitate changing solvents. To resolve two isomers of EuDOTTA in CD3CN,
the temperature was lowered to 233K. Once resolved (Figure 1), it is clear that the
distribution of SAP and TSAP isomers in CD3CN (mole fraction of the SAP isomer,
xSAP=0.67) is dramatically different from that published previously (D2O, 273 K),
5xSAP=0.33. It has been reported that a change in the solvent from D2O to CD3CN can
increase xSAP of EuDOTAM from 0.80 to 0.97.5 However, such a change is relatively
modest in comparison to that observed here for EuDOTTA in which the dominant isomer is
opposite in the two solvents. In addition to a change in the the isomeric distribution, a
change in the solvent also substanitally affects the rate of isomer interconversion and hence
the low-temperature requirement to resolve the two isomeric forms.
The rate of isomeric interconversion was also found to be accelerated for Yb1 upon a change
of the solvent fromD2O to CD3CN. However, this change in the solvent had an effect upon
the mole fraction xSAP opposite to that observed with EuDOTTA, dropping from 0.82 in
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D2O to 0.72 in CD3CN (Figure 1). This suggests that the nature of the trend with a change in
the solvent may be Ln3+ ion specific, given the strong relationship between the SAP/TSAP
ratio and the Ln3+ ionic radius. Nonetheless, the strong solvent dependency was found to
hold for all Ln3+ chelates tested with this ligand.
Eu2 is not readily soluble in water, but spectra could be obtained in CD3OD and CD3CN. In
this tetraamide system, the TSAP isomer predominated in CD3CN (xSAP = 0.05), while the
SAP isomer predominated (xSAP=0.70) in the protic solvent, CD3OD(Figure 2). The
dependence of the isomeric distribution upon the nature of the solvent is also not confined to
LnDOTA-tetraamide chelates. For example, in the cyclen tetrapyridyl complexes, Ln3, the
crystal and solution state structures of which have been described elsewhere,20,21 was also
found to be highly affected by the nature of the solvent. xSAP for Eu3 was found to drop
from 0.85 to 0.50 upon a change in the solvent fromD2OtoCD3CN(Figure 3).
The origins of these profound solvent-dependent changes in the isomeric distribution are
unclear. Because the counterion was triflate in all cases, the nature of the counterion can at
least be ruled out. However, a change in the solvent may alter the interaction between a
cationic chelate and its anions, which may translate into changes in isomerism. However, the
fact that a change from a protic to an aprotic solvent does not result in the same consistent
trend in isomerism tends to suggest that the underlying cause is more complex than the
simple disruption of ionic interaction.
The luminescent properties of Eu3+ provide a valuable means of probing its coordination
environment and, in particular, the nature of the capping axial ligand. Axial ligands of
differing polarizability can substantially alter Bleaney’s B02 ligand-field parameter,22 giving
rise to changes in the 1H NMR hyperfine shifts and the splitting of the 5D0 → 7F1 emission
band.23 SAP/TSAP isomerism has a similar effect on both of these parameters;24,25
however, incorrectly assigning either isomeric form as a result of such changes can be
discounted because both isomeric forms can be identified in each case. Nonetheless, the
commonality of this effect frustrated our attempts to probe the emission spectra of these
Eu3+ chelates for clues as to the origin of the changes in isomerism with a change in the
solvent. The emission spectra of these chelates are provided in the Supporting Information
for further examination (Figures S1 and S2). This leaves only the hydration state of the Eu3+
ion available for exploration. H2O and D2O were titrated into separate samples of Eu2 and
Eu3 in dry CH3CN, and the hydration state of the Eu3+ ion was determined by a modified
Horrocks’ method.26 The plot of q versus [H2O] (Figure S3 in the Supporting Information)
obtained for Eu2 resembles a classical binding curve but curiously plateaus with a q value of
~0.4. The curve obtained for Eu3 is more complex still (Figure S4 in the Supporting
Information), possibly because the counterion may become involved in the direct binding to
the Eu3+ center, a phenomenon observed in some crystal structures of this chelate.20
Nonetheless, each chelate demonstrates an increase in the hydration state as water is added
to the CH3CN solution of the chelate, strongly indicative of substitution of the axial ligand
as the solvent is changed.27
LnDOTA-tetraamide chelates that possess tertiary amides demonstrate a greater
predisposition for adopting a TSAP coordination geometry than their secondary amide
counterparts, even with very large amide substituents. Yet, the monobenzylic analogue of
Eu2, which is observed to predominate as the SAP isomer in CD3OD (xSAP>0.99; Figure S5
in the Supporting Information), also exhibits a change in the isomer ratio upon a change in
the solvent to CD3CN (xSAP = 0.77), a change that is coupled with an acceleration in the rate
of isomer interconversion. Although this change is not as a dramatic as that observed for
Eu2, it does raise questions about the assumptions that are made regarding isomeric ratios
when such systems are to be applied in vivo. In particular, if tertiary amide systems come to
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be viewed as a solution to offsetting the cationic nature of DOTA-tetraamide chelates, then
the question of how local environmental factors affect structural isomerism in these chelates
will become critical. Although the solvent for all in vivo applications is aqueous, it is not
homogeneous throughout extracellular space. Compartmentalization of water within tissue
leads to differences in the constituents of the solvent throughout tissue. Some components,
such as phosphate, phospholipids, and phosphorylated metabolites, may be capable of
substituting the axial ligand of tertiary LnDOTA-tetraamide chelates, which it seems plays
some role in influencing the isomer distribution. They may also affect the very nature of the
water itself, perturbing its inter- and intramolecular interactions and ultimately its
interactions with these chelates. If either of these alter the proportion of SAP isomer present
or the hydration state of the chelate, it would concomitantly affect the CEST contrast
observed in an imaging experiment. This may be an Achilles heel or an advantage that can
be exploited to gain additional information, but in either case, it is necessary to understand
these effects thoroughly before these systems can be applied in vivo.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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1H NMR spectra of EuDOTTA (top) and Yb1 (bottom) focusing on the highly shifted axS
resonance. Spectra were acquired at 400MHz inD2O at 300K(left) and in CD3CN at 233K
(right). Note that the hyperfine shifts of these resonances cannot be compared from one
solvent to another because of temperature differences.
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1H NMR spectra of Eu2 focusing on the highly shifted axS resonance. Spectra were acquired
at 400 MHz in CD3CN at 233 K (left) and in CD3OD at 298 K (right).
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1H NMR spectra of Eu3 focusing on the highly shifted axS resonance. Spectra were acquired
at 400MHz and 300K in D2O (left) and CD3CN (right).
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Structures of Macrocyclic Ligands Discussed in This Work
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